Serum laminin level and disease activity in primary membranous and membranoproliferative gomerulonephritis: A prospective follow-up?

Nephron

Volumn 73, Issue 2, 1996, Pages 367-

  Segarra, A ^a   SimO R ^a   Marti, R ^a   Sauri R ^a   Segura, R ^a   Ruiz, P ^a   Masmiquel, L L ^a   Piera, L L ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LAMININ;

ADULT; AGED; BLOOD; CLINICAL TRIAL; FEMALE; FOLLOW UP; HUMAN; LETTER; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; MIDDLE AGED; PROSPECTIVE STUDY;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; LAMININ; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 0029688353     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189091     Document Type: Article

References (3)

1. Segarra A. Masmiquel LL. Simó R. Segura RM. Sauri R, Piera LL: Which factors account for increased serum laminin levels in patients with chronic renal diseases? Nephron, in press.
2. Horikoshi S. Koide H: Serum laminin PI fragment concentration in renal disease. Clin Chim Acta 1991;196:185-191.
3. Pietschmann P. Schernthaner G. Schnack CH. Gaube S: Serum concentrations of laminin PI in diabetes with advanced nephropathy. J Clin Pathol 1988:41:929-932.